Stay updated on Dapagliflozin Impact on T2DM Risk Factors Clinical Trial
Sign up to get notified when there's something new on the Dapagliflozin Impact on T2DM Risk Factors Clinical Trial page.

Latest updates to the Dapagliflozin Impact on T2DM Risk Factors Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedUpdate: site displays new operating-status notice and new version v3.2.0; removal of a Genetics topic (Type 2 diabetes) and older version (v3.1.0) is noted.SummaryDifference3%
- Check22 days agoChange DetectedVersion update: from v3.0.2 to v3.1.0. The change is limited to the revision label; no core content or critical data appears to be altered.SummaryDifference0.1%
- Check37 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2; 'Back to Top' was removed.SummaryDifference0.2%
- Check44 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1.SummaryDifference0.2%
- Check51 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location, as well as new drug information related to Dapagliflozin and Metformin. However, several previous drug information topics and location details have been removed.SummaryDifference3%
- Check66 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
Stay in the know with updates to Dapagliflozin Impact on T2DM Risk Factors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dapagliflozin Impact on T2DM Risk Factors Clinical Trial page.